WEST PHARMACEUTICAL SERVICES (WST) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:WST - US9553061055 - Common Stock
275.52 USD
+0.29 (+0.11%)
275.52 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.887B 1.95% | 2.95B 2.18% | 2.893B -1.92% | 3.096B 7.01% | 3.288B 6.20% | 3.513B 6.84% | 3.732B 6.23% | 3.981B 6.67% | 4.139B 3.97% | |
| EBITDA YoY % growth | 875.5M -0.45% | 842.4M -3.78% | 744.9M -11.57% | 782.45M 5.04% | 861.13M 10.06% | 950.13M 10.34% | 1.052B 10.72% | 1.149B 9.22% | 1.207B 5.05% | |
| EBIT YoY % growth | 754.9M -0.30% | 705.1M -6.60% | 589.5M -16.39% | 615.11M 4.34% | 683.12M 11.06% | 766.87M 12.26% | 855.34M 11.54% | 934.62M 9.27% | 1.009B 7.96% | |
| Operating Margin | 26.15% | 23.90% | 20.38% | 19.87% | 20.78% | 21.83% | 22.92% | 23.48% | 24.38% | |
| EPS YoY % growth | 8.57 -0.46% | 8.08 -5.72% | 6.75 -16.46% | 7.18 6.31% | 7.85 9.39% | 8.87 12.94% | 9.92 11.95% | 10.93 10.11% | 12.15 11.18% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.85 1.76% | 1.66 14.63% | 1.97 7.16% | 2.07 5.77% | 2.08 12.46% | 1.89 13.43% | 2.18 10.65% | 2.33 12.54% | 2.32 11.37% |
| Revenue Q2Q % growth | 802.87M 7.22% | 765.82M 9.72% | 824.27M 7.54% | 844.81M 5.00% | 845.83M 5.35% | 826.59M 7.94% | 878.52M 6.58% | 916.6M 8.50% | 905.62M 7.07% |
| EBITDA Q2Q % growth | 206.19M -36.22% | 187.95M 13.02% | 218.35M -8.72% | 227.05M -23.68% | 226.99M 10.09% | 208.41M 10.89% | 236.09M 8.12% | 254.98M 12.30% | 250.27M 10.26% |
| EBIT Q2Q % growth | 162.98M -2.93% | 145.08M 14.87% | 172.95M 9.60% | 182.01M 5.15% | 182.26M 11.83% | 161.83M 11.55% | 190.45M 10.12% | 209.39M 15.04% | 204.63M 12.27% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.96 5.95% | 1.70 | 0.26 | 15.40% |
| Q2 2025 Q2Q % growth | 1.84 21.05% | 1.52 | 0.32 | 20.68% |
| Q1 2025 Q2Q % growth | 1.45 -7.05% | 1.25 | 0.20 | 16.40% |
| Q4 2024 Q2Q % growth | 1.82 -0.55% | 1.74 | 0.08 | 4.78% |
| Q3 2024 Q2Q % growth | 1.85 -14.35% | 1.52 | 0.33 | 22.11% |
| Q2 2024 Q2Q % growth | 1.52 -27.96% | 1.76 | -0.24 | -13.56% |
| Q1 2024 Q2Q % growth | 1.56 -21.21% | 1.29 | 0.27 | 21.26% |
| Q4 2023 Q2Q % growth | 1.83 3.39% | 1.80 | 0.03 | 1.93% |
| Q3 2023 Q2Q % growth | 2.16 6.40% | 1.87 | 0.29 | 15.21% |
| Q2 2023 Q2Q % growth | 2.11 -14.57% | 1.95 | 0.16 | 8.45% |
| Q1 2023 Q2Q % growth | 1.98 -13.91% | 1.69 | 0.29 | 17.48% |
| Q4 2022 Q2Q % growth | 1.77 -13.24% | 1.39 | 0.38 | 27.34% |
| Q3 2022 Q2Q % growth | 2.03 -1.46% | 2.14 | -0.11 | -5.19% |
| Q2 2022 Q2Q % growth | 2.47 0.41% | 2.24 | 0.23 | 10.49% |
| Q1 2022 Q2Q % growth | 2.30 12.20% | 2.14 | 0.16 | 7.25% |
| Q4 2021 Q2Q % growth | 2.04 52.24% | 1.93 | 0.11 | 5.47% |
| Q3 2021 Q2Q % growth | 2.06 79.13% | 1.81 | 0.25 | 13.52% |
| Q2 2021 Q2Q % growth | 2.46 96.80% | 1.76 | 0.70 | 39.98% |
| Q1 2021 Q2Q % growth | 2.05 102.97% | 1.45 | 0.60 | 41.77% |
| Q4 2020 Q2Q % growth | 1.34 | 1.14 | 0.20 | 17.93% |
| Q3 2020 Q2Q % growth | 1.15 | 1.01 | 0.14 | 14.15% |
| Q2 2020 Q2Q % growth | 1.25 | 0.92 | 0.33 | 36.38% |
| Q1 2020 Q2Q % growth | 1.01 | 0.83 | 0.18 | 21.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 804.6M 7.73% | 795.81M | 8.79M | 1.10% |
| Q2 2025 Q2Q % growth | 766.5M 9.17% | 734.72M | 31.78M | 4.33% |
| Q1 2025 Q2Q % growth | 698M 0.37% | 692.7M | 5.3M | 0.77% |
| Q4 2024 Q2Q % growth | 748.8M 2.30% | 747.88M | 920K | 0.12% |
| Q3 2024 Q2Q % growth | 746.9M -0.07% | 716.71M | 30.19M | 4.21% |
| Q2 2024 Q2Q % growth | 702.1M -6.86% | 736.64M | -34.54M | -4.69% |
| Q1 2024 Q2Q % growth | 695.4M -2.96% | 677.32M | 18.08M | 2.67% |
| Q4 2023 Q2Q % growth | 732M 3.29% | 746.86M | -14.86M | -1.99% |
| Q3 2023 Q2Q % growth | 747.4M 8.81% | 757.81M | -10.41M | -1.37% |
| Q2 2023 Q2Q % growth | 753.8M -2.27% | 763.26M | -9.46M | -1.24% |
| Q1 2023 Q2Q % growth | 716.6M -0.47% | 705.17M | 11.43M | 1.62% |
| Q4 2022 Q2Q % growth | 708.7M -3.02% | 663.74M | 44.96M | 6.77% |
| Q3 2022 Q2Q % growth | 686.9M -2.77% | 738.23M | -51.33M | -6.95% |
| Q2 2022 Q2Q % growth | 771.3M 6.59% | 764.77M | 6.53M | 0.85% |
| Q1 2022 Q2Q % growth | 720M 7.35% | 728.13M | -8.13M | -1.12% |
| Q4 2021 Q2Q % growth | 730.8M 25.96% | 717.3M | 13.5M | 1.88% |
| Q3 2021 Q2Q % growth | 706.5M 28.92% | 693.96M | 12.54M | 1.81% |
| Q2 2021 Q2Q % growth | 723.6M 37.25% | 676.08M | 47.52M | 7.03% |
| Q1 2021 Q2Q % growth | 670.7M 36.46% | 617.51M | 53.19M | 8.61% |
| Q4 2020 Q2Q % growth | 580.2M | 549.11M | 31.09M | 5.66% |
| Q3 2020 Q2Q % growth | 548M | 515.25M | 32.75M | 6.36% |
| Q2 2020 Q2Q % growth | 527.2M | 501.05M | 26.15M | 5.22% |
| Q1 2020 Q2Q % growth | 491.5M | 471.46M | 20.04M | 4.25% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.15% | 3.33% | 0.09% | 5.04% |
| Revenue | 0.01% | -0.16% | 0% | 0.68% |